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While it has been reported that ischemic stroke significantly increases the risk of 
delayed dementia,l.* the underlying mechanisms are not well understood. Hypoxic 
and ischemic (HI) injury resulting from cerebral hypoperfusion due to systemic 
illness has been proposed as a pathogenic mechanism in certain subgroups of 
 patient^.'.^ Thus, the aim of this study was to investigate whether cerebral HI injury 
resulting from certain systemic illnesses (e.g., cardiac arrhythmias, cardiac failure, 
pneumonia, seizures, sepsis) would be an independent risk factor for the develop- 
ment of incident dementia after ischemic stroke. 
METHODS 
We prospectively followed 185 initially nondemented ischemic stroke patients 
(mean age = 70.3 ? 7.7 years) and identified dementia in annual examinations 
using modified DSM-111-R criteria based on neuropsychological and functional 
assessments. A more extensive description of our recruitment and examination 
procedures is available in an earlier report of our methods and baseline findings! 
HI disorders were defined on the basis of previous and identified by means 
of chart review and/or patient examination during hospitalization. We used Kaplan- 
Meier analysis to determine the cumulative proportions of subjects surviving free 
of dementia in the groups of patients with and without HI disorders and Cox 
proportional hazards analysis to estimate the relative risk (RR) of incident dementia 
associated with the occurrence of these disorders. 
RESULTS 
As presented graphically in FIGURE 1, the cumulative proportion (+SE) of 
patients surviving free of dementia in the HI event group was 51.7% ? 10.9 versus 
78.2% ? 4.3 in the group of patients without a history of HI disorders after a 
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FIGURE 1. Graph of Kaplan-Meier analysis showing the cumulative proportion of patients 
surviving free of dementia stratified by hypoxic-ischemic (HI) status during the follow-up 
period up to 53 months. 
maximum of 52.8 months of follow-up. As shown in TABLE 1, the Cox analysis 
resulted in a relative risk [RR] of 4.28 (95% confidence interval [CI] = 1.92 to 9.55) 
for HI disorders as a predictor of incident dementia, after adjusting for demographic 
factors, recurrent stroke, and baseline cognitive function. Age was a significant 
covariate, with patients aged 70-79 and 280 years being at increased risk (RR = 
2.66, 95% CI = 1.17 to 6.06, and RR = 3.80, 95% CI = 1.25 to 11.60, respectively) 
relative to the 60-69-year-old reference group. Baseline MMSE score was also a 
significant predictor in the final model, with a RR of 3.55 (95% CI = 1.72 to 7.33), 
while recurrent stroke was not. 
DISCUSSION 
Our results suggest that HI disorders may be an independent risk factor for 
incident dementia after stroke. We found aparticularly high risk of delayed dementia 
in older patients with HI disorders, suggesting increased vulnerability with advancing 
age. Although the number of incident dementia cases in the HI patient group was 
small, our findings support the concept of a “cardiogenic” or hypoperfusion de- 
mentia. 
Consistent with our findings, Sulkava and Erkinjuntti’ have reported that 6 of 
133 patients (4.5%) with vascular dementia had experienced cerebral hypoperfusion 
resulting from systemic hypotension due to cardiac arrhythmias. CT brain imaging 
demonstrated white-matter lesions in five of the six patients, and vascular changes 
in the deep white matter and atheromatous disease affecting the circle of Willis 
were noted at autopsy in those patients. The authors speculated that atherosclerosis 
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TABLE 1. Relative Risk of Incident Dementia Based on Cox Proportional- 
Hazards Analysis for Hypoxic-Ischemic (HI) Stroke Patients Compared to 
Non-HI Stroke Patients Adjusting for Demographic Factors, Baseline Mini- 




Variable Final Model 
HI events (yes vs. no). 
Age (vs. 60-69 yr) 
4.28 
70-79 yr 2.66 
80+ yr 3.80 
5 8  yr 0.89 
9-12 yr 1.24 
Sex (women vs. men) 0.84 
Race (white vs. nonwhite) 0.47 
Recurrent stroke (yes vs. no). 1.72 
Education (vs. 13+ yr) 










NoIE. CI = Confidence Interval; HI = Hypoxic-ischemic; MMSE = Mini-Mental State 
Examination at 7-10 or 30 days after stroke (not used for the purpose of dementia diagnosis). 
a Time-dependent covariatc. 
of the deep penetrating arteries predisposed to hypoperfusion of the white matter 
in the setting of a decrease in systemic blood pressure. Among 175 consecutive 
autopsy cases of dementia, Brun3 found that 29% of the patients with vascular 
dementia had pathologic evidence of cerebral hypoperfusion with either selective 
incomplete infarction of the white matter or borderzone infarction. In population- 
based studies, Skoog et aLR found that 4.1% of 147 85-year-old patients with dementia 
had cerebral hypoperfusion as the primary basis for their dementia syndrome, while 
investigators in the Cardiovascular Health Study' reported that white-matter lesions 
on brain MRI were significantly associated with episodes of orthostatic hypotension. 
Finally, misuse of antihypertensive agents can lead to hypotensive episodes and, 
potentially, to cognitive decline in elderly patients.'" 
In conclusion, cerebral HI injury resulting from hypoperfusion due to systemic 
hypotension in the setting of co-morbid medical illnesses or misuse of antihyperten- 
sive agents may be an important pathogenic mechanism in the development of 
incident dementia after stroke. Early recognition of HI disorders may allow targeted 
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